DE2949407A1 - Verfahren zur gewinnung von (alpha) -2-sb-glykoprotein - Google Patents

Verfahren zur gewinnung von (alpha) -2-sb-glykoprotein

Info

Publication number
DE2949407A1
DE2949407A1 DE19792949407 DE2949407A DE2949407A1 DE 2949407 A1 DE2949407 A1 DE 2949407A1 DE 19792949407 DE19792949407 DE 19792949407 DE 2949407 A DE2949407 A DE 2949407A DE 2949407 A1 DE2949407 A1 DE 2949407A1
Authority
DE
Germany
Prior art keywords
protein
glycoprotein
carrier
buffer
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19792949407
Other languages
German (de)
English (en)
Inventor
Winfried Dr.phil. 8121 Pähl Albert
Walter 8131 Bernried Eberle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19792949407 priority Critical patent/DE2949407A1/de
Priority to US06/208,759 priority patent/US4325867A/en
Priority to DE8080107565T priority patent/DE3063994D1/de
Priority to EP80107565A priority patent/EP0030363B1/de
Priority to AT80107565T priority patent/ATE3981T1/de
Priority to JP17107780A priority patent/JPS5692297A/ja
Publication of DE2949407A1 publication Critical patent/DE2949407A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19792949407 1979-12-07 1979-12-07 Verfahren zur gewinnung von (alpha) -2-sb-glykoprotein Withdrawn DE2949407A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE19792949407 DE2949407A1 (de) 1979-12-07 1979-12-07 Verfahren zur gewinnung von (alpha) -2-sb-glykoprotein
US06/208,759 US4325867A (en) 1979-12-07 1980-11-20 Process for the recovery of α-2-SB-glycoprotein
DE8080107565T DE3063994D1 (en) 1979-12-07 1980-12-03 Process for obtaining alpha-2-sb-glycoprotein
EP80107565A EP0030363B1 (de) 1979-12-07 1980-12-03 Verfahren zur Gewinnung von alpha-2-SB-Glykoprotein
AT80107565T ATE3981T1 (de) 1979-12-07 1980-12-03 Verfahren zur gewinnung von alpha-2-sbglykoprotein.
JP17107780A JPS5692297A (en) 1979-12-07 1980-12-05 Recovery of alphaa22sbbsugar protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792949407 DE2949407A1 (de) 1979-12-07 1979-12-07 Verfahren zur gewinnung von (alpha) -2-sb-glykoprotein

Publications (1)

Publication Number Publication Date
DE2949407A1 true DE2949407A1 (de) 1981-06-11

Family

ID=6087908

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19792949407 Withdrawn DE2949407A1 (de) 1979-12-07 1979-12-07 Verfahren zur gewinnung von (alpha) -2-sb-glykoprotein
DE8080107565T Expired DE3063994D1 (en) 1979-12-07 1980-12-03 Process for obtaining alpha-2-sb-glycoprotein

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8080107565T Expired DE3063994D1 (en) 1979-12-07 1980-12-03 Process for obtaining alpha-2-sb-glycoprotein

Country Status (5)

Country Link
US (1) US4325867A (enExample)
EP (1) EP0030363B1 (enExample)
JP (1) JPS5692297A (enExample)
AT (1) ATE3981T1 (enExample)
DE (2) DE2949407A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
US5019087A (en) * 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5223440A (en) * 1987-11-17 1993-06-29 Adeza Biomedical Corporation Ex vivo product of conception test to determine abortion
US5185270A (en) * 1987-11-17 1993-02-09 Adeza Biomedical Corporation Fetal fibronectin pregnancy test
US5549904A (en) * 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US6660486B2 (en) * 2001-05-31 2003-12-09 Bio-Rad Laboratories, Inc. FXIII detection for verifying serum sample and sample size and for detecting dilution
EP1494030B1 (en) * 2003-06-30 2013-11-27 Sysmex Corporation Sample pretreatment solution for influenza virus test by immunochromatography

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2221261A1 (de) * 1972-04-29 1973-11-15 Behringwerke Ag Ap-glykoproteine und verfahren zu ihrer isolierung
DE2256910C3 (de) * 1972-11-20 1980-07-10 Behringwerke Ag, 3550 Marburg Metallionenbindendes 93 S-A1 -Glykoprotein und seine Verwendung
US4104266A (en) * 1977-04-14 1978-08-01 American National Red Cross Method for preparation of antihemophilic factor
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma

Also Published As

Publication number Publication date
US4325867A (en) 1982-04-20
JPS5692297A (en) 1981-07-25
EP0030363A3 (en) 1982-03-17
EP0030363A2 (de) 1981-06-17
ATE3981T1 (de) 1983-07-15
JPH0114240B2 (enExample) 1989-03-10
EP0030363B1 (de) 1983-06-29
DE3063994D1 (en) 1983-08-04

Similar Documents

Publication Publication Date Title
DE2661112C2 (de) Verfahren zur Herstellung eines unlöslichen Trägers
DE3280469T2 (de) Ultrareinigung des Faktors VIII.
DE2430357C2 (de) Verfahren zur qualitativen oder quantitativen Feststellung von Immunoglobulin der IgG-Klasse
DE2646854C2 (enExample)
DE2655084C2 (enExample)
EP0073514A1 (de) Creatinin-Antikörper
CH647158A5 (de) Verfahren zur reinigung von interferon.
DE3034142C2 (enExample)
EP1789445B1 (de) Verfahren zur entfernung von fibronektin aus plasmafraktionen
EP0030363B1 (de) Verfahren zur Gewinnung von alpha-2-SB-Glykoprotein
DE3623846C2 (de) Zusammensetzung zur selektiven Bestimmung einer biologisch aktiven Substanz
DE3224217A1 (de) Enzymimmunoassay-methode zur qualitativen und quantitativen bestimmung von substanzen
DE10029705A1 (de) Herstellung von IgY(AFc)-Antikörpern und deren Verwendung
EP0141326B1 (de) Neues Protein PP20, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE2102514B2 (de) Verfahren zur chemischen kupplung von biologisch wirksamen stoffen an ein hydrophiles polymer
DE3525911A1 (de) Konjugat fuer die enzymimmunobestimmung
DE3688713T2 (de) Verfahren zur Stabilisierung eines Urokinasevorläufers und diesen Vorläufer enthaltendes trockenes Präparat.
DE2952815C1 (de) Verfahren zur Konservierung von immobilisierten Eiweissstoffen
DE3024270C2 (de) Zusammensetzung zur Bestimmung des menschlichen Erythropoietins und Verfahren zu dessen Bestimmung
DE2428955C3 (de) Verfahren zur Abtrennung der enzymatischen Komponente mit in vivo antikoagulierender und in vitro koagulierender Wirkung aus dem Gift der Schlange Ancistrodon rhodostoma und daraus hergestellte Mittel
DE2061009A1 (de) Verfahren zur Fixierung von Polymeren
DE2908053C2 (de) Verfahren und Reagenz zur Bestimmung der Creatinkinase MB
EP0332985B1 (de) Verfahren zum affinitätschromatografischen Reinigen von Faktor XIII
DE2353973A1 (de) Steroid-bindendes globulin und verfahren zu dessen herstellung
DE68912891T2 (de) Verfahren zum Beseitigen von Pyrogenen.

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee